Compound bovine fetal liver extract tablets
Function and Efficacy
This product, through the action of cytokines such as IGF1, FGF and inositol, induces the polysaccharide protein receptors of liver cell membranes and mitochondrial membranes, increases the activity of ATP synthase, promotes the cell's uptake and utilization of glucose, and increases energy synthesis. This product can promote the combination of fatty acids and apolipoproteins and their entry into the blood, reduce fat accumulation in the liver, promote fatty acid beta-oxidation, and accelerate fat decomposition.
Ingredients
This product is a compound preparation, whose ingredients are bovine fetal liver extract (containing a variety of liver-derived peptide cytokines such as IGF1, FGF, TGFS, HGF), vitamin B12, and inositol.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| Vitamin B12Ingredients |
This product, through the action of cytokines such as IGF1, FGF and inositol, induces the polysaccharide protein receptors of liver cell membranes and mitochondrial membranes, increases the activity of ATP synthase, promotes the cell's uptake and utilization of glucose, and increases energy synthesis. This product can promote the combination of fatty acids and apolipoproteins and their entry into the blood, reduce fat accumulation in the liver, promote fatty acid beta-oxidation, and accelerate fat decomposition. More |
68-19-9 | 16 | |
| InositolIngredients |
It participates in inducing the glycoprotein receptors on the liver cell membrane and mitochondrial membrane, increasing the activity of ATP synthase, promoting the uptake and utilization of glucose by cells, and increasing energy synthesis. More |
87-89-8 | 8 |
Appearance
This product is a film-coated tablet. After removing the film coating, it is light brown.
Indication
Acute hepatitis | Chronic hepatitis | Liver fibrosis | Fatty liver | Cirrhosis
Usage and Dosage
Oral administration: 1-2 tablets at a time, 3 times a day, 15-30 days as a course of treatment.
Adverse Reactions
No adverse reactions have been found.
Precautions
1. It is contraindicated for patients with acute liver atrophy or hepatic coma. 2. It is contraindicated for patients who are allergic to this product.
Special Population Medication
Precautions for children: The safety of the drug in children has not been confirmed. Precautions for pregnancy and lactation: No such experiment has been conducted and there are no reliable references. Precautions for the elderly: The safety of the drug in elderly patients has not been confirmed.
Drug Interactions
This experiment has not been conducted and there are no reliable references.
Storage
Keep away from light and store in sealed container.
Packaging Specification
40mg(peptide)
Validity Period
Tentative 24 months
Manufacturer
Heilongjiang Jiangshi Pharmaceutical Co., Ltd.
-
Founded in:
1998-07-27 -
Address:
No. 2 Weihai Road, Pingfang Economic and Technological Development Zone, Harbin City, Heilongjiang Province -
Tax NO.:
91230199702846035D -
Registered Funds:
5 million yuan -
Website:
-
Email: